Call for Papers   a href="https://bentham.manuscriptpoint.com/journals/acamc" class="submit_manuscript">Call for Papers  

Article Details


HCA587 Protein Vaccine Induces Specific Antitumor Immunity Mediated by CD4<sup>+</sup> T-cells Expressing Granzyme B in a Mouse Model of Melanoma

[ Vol. 21 , Issue. 6 ]

Author(s):

Weiming Yang, Weiheng Zhang, Xiaozhong Wang, Liming Tan, Hua Li, Jiemin Wu, Qiong Wu, Wanlei Sun, Juanjuan Chen* and Yanhui Yin*   Pages 738 - 746 ( 9 )

Abstract:


<P>Background: The antigen HCA587 (also known as MAGE-C2), which is considered a cancer-testis antigen, exhibits upregulated expression in a wide range of malignant tumors with unique immunological properties, and may thus serve as a promising target for tumor immunotherapy. </P><P> Objective: The study aimed to explore the antitumor effect of the HCA587 protein vaccine and the response of humoral and cell-mediated immunity. </P><P> Methods: The HCA587 protein vaccine was formulated with adjuvants CpG and ISCOM. B16 melanoma cells were subcutaneously inoculated to C57BL/6 mice, followed by treatment with HCA587 protein vaccine subcutaneously. Mouse survival was monitored daily, and tumor volume was measured every 2 to 3 days. The tumor sizes, survival time and immune cells in tumor tissues were detected. And the vital immune cell subset and effector molecules were explored. </P><P> Results: After treatment with HCA587 protein vaccine, the vaccination elicited significant immune responses, which delayed tumor growth and improved animal survival. The vaccination increased the proportion of CD4<sup>+</sup> T cells expressing IFN-&#947; and granzyme B in tumor tissues. The depletion of CD4<sup>+</sup>T cells resulted in an almost complete abrogation of the antitumor effect of the vaccination, suggesting that the antitumor efficacy was mediated by CD4<sup>+</sup> T cells. In addition, knockout of IFN-&#947; resulted in a decrease in granzyme B levels, which were secreted by CD4<sup>+</sup> T cells, and the antitumor effect was also significantly attenuated. </P><P> Conclusion: The HCA587 protein vaccine may increase the levels of granzyme B expressed by CD4<sup>+</sup> T cells, and this increase is dependent on IFN-&#947;, and the vaccine resulted in a specific tumor immune response and subsequent eradication of the tumor.</P>

Keywords:

HCA587 protein vaccine, antitumor immunity, granzyme B, cytotoxic CD4<sup>+</sup> T cell, immunotherapy, melanoma.

Affiliation:

Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, Jiangxi Province Key Laboratory of Laboratory Medicine, Nanchang 330006, Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, Jiangxi Province Key Laboratory of Laboratory Medicine, Nanchang 330006, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, Jiangxi Province Key Laboratory of Laboratory Medicine, Nanchang 330006, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, Jiangxi Province Key Laboratory of Laboratory Medicine, Nanchang 330006, Department of Clinical Laboratory, Wuyuan County People's Hospital, Wuyuan 333200, Jiangxi Province, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, Jiangxi Province Key Laboratory of Laboratory Medicine, Nanchang 330006, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, Jiangxi Province Key Laboratory of Laboratory Medicine, Nanchang 330006, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, Jiangxi Province Key Laboratory of Laboratory Medicine, Nanchang 330006, Department of Immunology, School of Basic Medical Sciences, and Key Laboratory of Medical Immunology of Ministry of Health, Peking University Health Science Center, Beijing 100191

Graphical Abstract:



Read Full-Text article